A new era of cancer screening: Early lung cancer detection with a simple, non-invasive blood test, vastly improving survival outcomes in millions of high-risk individuals.
Our mission is to pioneer early lung cancer detection and save lives.
Our vision is a future where our revolutionary blood test detects lung cancer at its most treatable stage, dramatically improving survival rates worldwide. By making our screening test a routine procedure, we empower at-risk individuals to proactively manage their health and change the course of this deadly disease.
A Simple Blood Test, A Giant Leap in Cancer Detection
We use a unique 6-protein panel that acts as a precise identifier to differentiate lung cancer patients from healthy individuals. This is how it works:
First, a standard blood sample is taken, just like during a regular check-up at your family doctor or a clinic. This sample contains something called plasma, which is key to our testing. In lung cancer patients, we’ve found that five of these proteins are found in higher amounts than usual, while one is found in a lower amount. Think of these proteins as markers or flags that signal the presence of lung cancer. An algorithm evaluates from the resulting data points if a person is likely to have lung cancer or not.
Rapid innovation is also critical to our mission
At Aerion Bioscience, we’re on the forefront of transforming lung cancer detection. Our breakthrough 6-protein biomarker panel has not only shown promise in preliminary clinical testing for early detection of lung cancer, furthermore we’ve successfully tested it in a second clinical group. Our focus for the near future is clear and ambitious – we’re expanding our tests to include a wider range of lung cancer samples, healthy individuals, and even other lung conditions. This broad testing is crucial for us to understand if our markers can not only detect lung cancer but also distinguish its various stages, evaluate its aggressiveness, and possibly identify other lung diseases like chronic obstructive pulmonary disease.
